论文部分内容阅读
目的对支气管成形肺叶切除治疗中心型肺癌的临床疗效进行评估。方法 16例中心型肺癌患者,对其进行支气管成形切除治疗,其中支气管袖状成形肺叶切除术9例,支气管楔形肺叶切除术5例,支气管肺血管双成形术2例。结果术后16例患者中无死亡病例发生,发生术后并发症5例(31.25%),其中肺不张3例,肺部感染1例,支气管胸膜瘘1例,并发症经相应处理均治愈。术后随访1~36个月,其中术后1年的生存例数为15例(93.75%),术后3年的生存例数为11例(68.75%)。结论采用支气管成形肺叶切除术治疗中心型肺癌,能提高肺癌切除率,最大限度的保留患者肺功能,术后并发症发生风险低,长期生存率高,值得临床推广。
Objective To evaluate the clinical efficacy of bronchogenic lobectomy in the treatment of central lung cancer. Methods Sixteen patients with central lung cancer were treated with bronchoplasty, including 9 cases of bronchial sleeve lobe resection, 5 cases of bronchial wedge lobectomy and 2 cases of bronchial and pulmonary vascular double plasty. Results No postoperative death occurred in 16 patients. Postoperative complications occurred in 5 patients (31.25%), including 3 cases of atelectasis, 1 case of pulmonary infection and 1 case of bronchopleural fistula. The complications were cured by corresponding treatment . The patients were followed up for 1 to 36 months, of which 15 cases (93.75%) survived one year after operation and 11 cases (68.75%) after 3 years of operation. Conclusions Bronchogenic lobectomy for central lung cancer can improve the resection rate of lung cancer and maximize the lung function. The risk of postoperative complications is low and the long-term survival rate is high, which is worthy of clinical promotion.